drugset / Trial / NCT05283317
Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock
Non-randomizedParallel-groupSingle-blindTreatment
Summary
Methods:Ten patients were enrolled in the study. Adipose derived-MSCs infusions were given (1x 106/ kg, on 1st, 3rd, 5th, 7th and 9th days of therapy) together with Standard therapy. Before the MSCs applications, blood samples were collected for cytokine assessment (TNF-α, IFN-γ, IL-2, IL-4, IL-6, IL-10). The clinical and laboratory improvements were recorded and compared with control groups selected retrospectively.
Timeline
- Start
- 2018-03-11
- Primary completion
- 2019-08-25
- Completion
- 2019-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | mesenchymal stem cells | Cell therapy | 1e+06 cells/kg | Intravenous |